Penn Center for Innovation

Symposium: Cellicon Valley ’21: The Future of Cell and Gene Therapies

Posted on March 18, 2021 — Jessica Jones Gupta

Participants will leave with up-to-date, practical information which will have immediate clinical application, and an understanding of critical research initiatives that are rapidly driving this field forward, as well as the technical and scientific background on the current state, and where the latest scientific advances may take the field.

Virtual Symposium, Thurs, May 6 – Fri, May 7. Register here

Upon completion of this symposium, participants should be able to:

  • Identify current application of CAR T-cell therapy including: disease indication, accurate patient selection, manufacture and treatment administration
  • List approaches to overcome resistance to monotherapy CAR’s
  • Implement guidelines for patient management, and identify causes of toxicities of CAR T-cell therapies including cytokine release syndrome and neurologic toxicity.
  • Describe gene delivery and editing for CARs
  • Identify the latest targets and technologies for CARs
  • Identify the current status of globalization of CAR T-cell therapies and identify principles in ethics of patient access
  • Describe current approaches in treatment and supportive care for hematopoietic stem cell transplantation (HSCT) in pediatric patients with nonmalignant conditions
  • Identify the latest evidence based standards in nursing care resulting from the recent advances in cell/gene therapy and transplant
Category: events, news, pci